Business Wire

IBC

Share
IBC Launches 365 Online Community Platform for Global Media, Entertainment and Technology Industry

IBC is delighted to announce the launch of IBC365 at www.ibc.org , a new online community platform and weekly e-bulletin that will share IBC’s unparalleled business knowledge and insight through fresh and original content, throughout the year.

As part of IBC’s remit to be run “by the industry, for the industry”, the organisation recently commissioned extensive independent research to take the pulse of the broadcast and media industry and pinpoint areas where IBC could offer greater value to 1,700+ exhibitors and 55,000+ visitors of the IBC Show in Amsterdam in September. A key finding of the research was a desire for more IBC-generated industry insight outside of show time.

IBC Chief Executive Michael Crimp said: “For several years IBC stakeholders have asked for access to the wealth of knowledge generated by our wide range of industry experts. IBC365 enables us to deliver this invaluable market information and high quality content whenever and wherever it is needed. This will also allow us to reach out to new markets and draw them into the IBC community.”

In addition to serving the broadcast and media community, the research also identified a number of key adjacent markets such as Cloud, AR/VR, Mobile, IoT, Social Networks, Artificial Intelligence and Telcoms, which would benefit from IBC’s industry expertise.

IBC365 went live today with hundreds of articles and videos, including industry trends, executive interviews, thought leadership, technology papers and sponsored content across Production, Content Management, Delivery, Consumption and Technology Advances. Commissioned content specifically aimed at adjacent markets will engage them more fully with IBC. The editorial output of IBC365 will also align with the themes, sessions and speakers at IBC2017.

IBC’s leading team of writers, consultants and analysts includes Fergal Ringrose, formerly Editor-in-Chief of TVB Europe and the IBC Daily, as Executive Editor, and George Bevir, formerly Technology and Facilities Editor of Broadcast and Editor of Broadcast Tech, in the role of Editor.

IBC365, which can be found at ibc.org, goes live today.

## ENDS ##

About IBC

IBC is the premier annual event for professionals engaged in the creation, management and delivery of content worldwide. Attracting 55,000+ attendees from more than 170 countries, IBC combines a highly respected and peer-reviewed conference with an exhibition that exhibits more than 1,700 leading suppliers of state of the art electronic media technology and provides unrivalled networking opportunities.

IBC2017 Dates:

Conference: 14 - 18 September 2017

Exhibition: 15 - 19 September 2017

For more information about IBC365 go to www.ibc.org

For more information about IBC2017 visit show.ibc.org

Contact:

For IBC
Louise Wells, Bubble Communications
E: louisew@bubbleagency.com
T: +44 7718 985 252

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release

- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release

With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp

Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release

The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev

7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release

MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t

First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release

Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye